The capsule & tablet counter market is projected to grow from USD 1.0 billion in 2026 to USD 1.9 billion by 2036, at a CAGR of 6.5%. Automatic counters will dominate with a 45.0% market share, while pharma manufacturing will lead the application segment with a 55.0% share.